New Ray Medicine International Holding Limited (HKG:2908)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
0.4000
-0.0050 (-1.23%)
At close: Aug 1, 2025, 4:00 PM HKT

Accolade Statistics

Total Valuation

HKG:2908 has a market cap or net worth of HKD 66.87 million. The enterprise value is 6.17 million.

Market Cap66.87M
Enterprise Value 6.17M

Important Dates

The next estimated earnings date is Wednesday, August 27, 2025.

Earnings Date Aug 27, 2025
Ex-Dividend Date n/a

Share Statistics

Current Share Class n/a
Shares Outstanding n/a
Shares Change (YoY) n/a
Shares Change (QoQ) +0.00%
Owned by Insiders (%) n/a
Owned by Institutions (%) n/a
Float 96.40M

Valuation Ratios

PE Ratio n/a
Forward PE n/a
PS Ratio 0.71
PB Ratio 0.14
P/TBV Ratio 0.14
P/FCF Ratio n/a
P/OCF Ratio n/a
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

EV / Earnings -0.20
EV / Sales 0.07
EV / EBITDA n/a
EV / EBIT n/a
EV / FCF -1.14

Financial Position

The company has a current ratio of 12.01, with a Debt / Equity ratio of 0.01.

Current Ratio 12.01
Quick Ratio 4.76
Debt / Equity 0.01
Debt / EBITDA n/a
Debt / FCF -0.66
Interest Coverage -371.91

Financial Efficiency

Return on equity (ROE) is -6.52% and return on invested capital (ROIC) is -4.97%.

Return on Equity (ROE) -6.52%
Return on Assets (ROA) -4.76%
Return on Invested Capital (ROIC) -4.97%
Return on Capital Employed (ROCE) -7.94%
Revenue Per Employee 3.24M
Profits Per Employee -1.07M
Employee Count29
Asset Turnover 0.19
Inventory Turnover 3.73

Taxes

Income Tax -1.05M
Effective Tax Rate n/a

Stock Price Statistics

Beta (5Y) n/a
52-Week Price Change n/a
50-Day Moving Average n/a
200-Day Moving Average n/a
Relative Strength Index (RSI) n/a
Average Volume (20 Days) 222,187

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, HKG:2908 had revenue of HKD 93.95 million and -31.01 million in losses. Loss per share was -0.19.

Revenue93.95M
Gross Profit -1.62M
Operating Income -37.94M
Pretax Income -32.06M
Net Income -31.01M
EBITDA -36.23M
EBIT -37.94M
Loss Per Share -0.19
Full Income Statement

Balance Sheet

The company has 64.26 million in cash and 3.55 million in debt, giving a net cash position of 60.71 million.

Cash & Cash Equivalents 64.26M
Total Debt 3.55M
Net Cash 60.71M
Net Cash Per Share n/a
Equity (Book Value) 470.96M
Book Value Per Share 2.82
Working Capital 300.61M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -4.77 million and capital expenditures -622,000, giving a free cash flow of -5.39 million.

Operating Cash Flow -4.77M
Capital Expenditures -622,000
Free Cash Flow -5.39M
FCF Per Share n/a
Full Cash Flow Statement

Margins

Gross margin is -1.73%, with operating and profit margins of -40.38% and -33.01%.

Gross Margin -1.73%
Operating Margin -40.38%
Pretax Margin -34.13%
Profit Margin -33.01%
EBITDA Margin -38.57%
EBIT Margin -40.38%
FCF Margin n/a

Dividends & Yields

HKG:2908 does not appear to pay any dividends at this time.

Dividend Per Share n/a
Dividend Yield n/a
Dividend Growth (YoY) n/a
Years of Dividend Growth n/a
Payout Ratio n/a
Buyback Yield n/a
Shareholder Yield n/a
Earnings Yield -46.38%
FCF Yield -8.06%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value n/a
Lynch Upside n/a
Graham Number n/a
Graham Upside n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date n/a
Split Type n/a
Split Ratio n/a

Scores

HKG:2908 has an Altman Z-Score of 1.67 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score 1.67
Piotroski F-Score 2